Biosynthetic Pathways of Antibiotic-Producing Actinomycetes

Actinomycetes represent a prolific source of clinically important antibiotics, synthesising structurally diverse compounds through modular enzyme assemblies encoded within discrete biosynthetic gene clusters. Central to this capacity are polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs), large multi‐domain enzymes that iteratively assemble simple starter units into complex polyketide or peptide backbones. Subsequent tailoring by oxygenases, glycosyltransferases, methyltransferases and resistance factors introduces chemical diversity and self‐protection mechanisms. Regulation of these clusters occurs at multiple levels, from pathway‐specific transcriptional regulators to global two‐component systems, ensuring production in response to ecological cues. By elucidating the genetic architecture and enzymatic choreography of these pathways, researchers have uncovered strategies to unlock cryptic clusters, engineer new analogues and optimise fermentation for industrial scale-up. This work underscores the global significance of actinomycete biosynthesis in addressing antimicrobial resistance and driving sustainable manufacturing of next-generation therapeutics.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Biosynthetic Pathways of Antibiotic-Producing Actinomycetes publication trend

The graph below shows the total number of articles in biosynthetic pathways of antibiotic-producing actinomycetes across all publications each year (not limited to Nature Index journals).

Technical terms

Polyketide synthase (PKS): Modular enzyme complex that assembles acyl‐CoA building blocks into diverse polyketide scaffolds.

Nonribosomal peptide synthetase (NRPS): Multi‐enzyme assembly line that condenses amino acid monomers into nonproteinogenic peptides.

Cytochrome P450 hydroxylase: Heme‐containing monooxygenase that introduces oxygen functionalities into polyketide backbones.

Glycosyltransferase: Enzyme that attaches sugar moieties to aglycone cores, modulating activity, solubility and self‐resistance.

Autotoxicity: Inhibition of producing organisms by their own antibiotic products, often overcome by efflux pumps or sequestration.

Response-surface methodology: Statistical tool for optimising multiple variables in fermentation media to maximise product yield.

References

1. Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism. International Journal of Molecular Sciences (2023).
2. Enhancement of doxorubicin production in Streptomyces peucetius by genetic engineering and process optimization. AMB Express (2024).
3. Autonomous Defense Based on Biogenic Nanoparticle Formation in Daunomycin-Producing Streptomyces. Microorganisms (2025).